Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
176
DELISTED
Unilever NV New York Registry Shares
UN
| $49.5M | 0.05% |
861,834
-18,181
| -2% | -$1.07M |
|
177
Stratasys
SSYS
$679M
| $48M | 0.05% |
2,371,871
-151,710
| -6% | -$3.02M |
|
178
Artisan Partners
APAM
$2.79B
| $47.8M | 0.05% |
1,479,549
-126,816
| -8% | -$3.66M |
|
|
BECN
179
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $46.7M | 0.05% |
1,460,447
-90,974
| -6% | -$2.88M |
|
180
NETSCOUT
NTCT
$2.96B
| $46M | 0.05% |
1,912,899
-616,724
| -24% | -$14.6M |
|
181
MSCI
MSCI
$41.6B
| $44.3M | 0.04% |
171,577
-26,200
| -13% | -$6.39M |
|
182
Equinor
EQNR
$97.7B
| $43.8M | 0.04% |
2,201,278
-32,159
| -1% | -$608K |
|
183
Diageo
DEO
$49B
| $43.7M | 0.04% |
259,276
-5,751
| -2% | -$935K |
|
184
ENI
E
$80.5B
| $42.7M | 0.04% |
1,379,774
-108,405
| -7% | -$3.32M |
|
185
Texas Instruments
TXN
$252B
| $42.7M | 0.04% |
332,685
-134,998
| -29% | -$16.7M |
|
186
Oceaneering
OII
$4.86B
| $41.5M | 0.04% |
2,783,051
-757,648
| -21% | -$10.5M |
|
187
ServiceNow
NOW
$115B
| $41.2M | 0.04% |
730,475
+102,630
| +16% | +$5.41M |
|
188
Integra LifeSciences
IART
$1.29B
| $40.7M | 0.04% |
697,710
-30,348
| -4% | -$1.81M |
|
|
MZTI
189
The Marzetti Company
MZTI
$2.93B
| $40.6M | 0.04% |
253,793
-9,896
| -4% | -$1.49M |
|
190
Intuitive Surgical
ISRG
$127B
| $39.6M | 0.04% |
200,790
-55,731
| -22% | -$10.4M |
|
191
Gerdau
GGB
$9.74B
| $39.1M | 0.04% |
10,060,039
+1,674,584
| +20% | +$4.98M |
|
192
RLJ Lodging Trust
RLJ
$1.86B
| $39.1M | 0.04% |
2,205,687
-307,913
| -12% | -$5.23M |
|
193
Core Laboratories
CLB
$490M
| $38M | 0.04% |
1,008,483
-59,694
| -6% | -$2.68M |
|
194
AAR Corp
AIR
$5.59B
| $36.6M | 0.04% |
811,076
-175,448
| -18% | -$7.62M |
|
195
Medpace
MEDP
$16.1B
| $35M | 0.04% |
416,538
+108,615
| +35% | +$8.41M |
|
196
Emergent Biosolutions
EBS
$373M
| $34M | 0.03% |
630,984
-30,587
| -5% | -$1.66M |
|
197
Prestige Consumer Healthcare
PBH
$2.38B
| $33M | 0.03% |
814,347
-19,974
| -2% | -$745K |
|
198
CONMED
CNMD
$1.39B
| $32.9M | 0.03% |
294,634
-70,310
| -19% | -$7.49M |
|
199
Ecopetrol
EC
$34.5B
| $32.9M | 0.03% |
1,650,499
-504,230
| -23% | -$9.29M |
|
200
Gilead Sciences
GILD
$162B
| $32.9M | 0.03% |
505,787
-146,467
| -22% | -$9.54M |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.